Standout Papers

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease 2017 2026 2020 2023 403
  1. A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease (2017)
    Susanne Ostrowitzki, Robert Lasser et al. Alzheimer s Research & Therapy

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 67 standout
Sub-graph 1 of 22

Citing Papers

A natural experiment on the effect of herpes zoster vaccination on dementia
2025 StandoutNature
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
2025 Standout
1 intermediate paper

Works of Carsten Hofmann being referenced

Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans
2023
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
2017 Standout

Author Peers

Author Last Decade Papers Cites
Carsten Hofmann 602 346 468 41 1.3k
Alan R. Kugler 429 212 290 39 1.7k
Celedon Gonzales 894 367 695 31 1.6k
Mary Pat Knadler 182 201 583 43 1.5k
Achiel Van Peer 81 207 213 43 1.2k
Cuiping Chen 143 362 161 58 1.7k
D. Garceau 636 326 337 30 1.1k
W Ma 503 338 176 19 1.1k
Aimée Dallob 200 209 636 27 1.2k
N. Christophidis 239 197 233 34 1.1k
Trine Meldgaard Lund 318 450 116 65 1.3k

All Works

Loading papers...

Rankless by CCL
2026